Vertex Pharmaceuticals (VRTX)

Income Tax Expense

$292.00M

Quarterly · Period ending: · USD

VRTX logo

VRTX Income Tax Expense

Latest reported$292.00M
VRTX Quarterly Income Tax ($0.00 → $292.00M)
High-resolution chart · PNG

VRTX income tax expense history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Income Tax Expense — Quarterly (USD)
Period endingIncome Tax Expense (USD)
292,000,000
221,500,000
139,900,000
215,900,000
250,100,000
84,100,000
223,500,000
178,700,000
202,400,000
179,500,000
178,800,000
143,900,000
245,800,000
191,700,000
257,900,000
245,900,000
213,900,000
192,700,000
100,800,000
230,813,000
-111,179,000
167,822,000
284,433,000
78,437,000
-12,500,000
54,781,000
93,716,000
13,148,000
59,711,000
51,534,000
-1,492,599,000
8,055,000
10,341,000
-12,659,000
10,257,000
-125,903,000
4,337,000
3,985,000
-7,453,000
503,000
18,130,000
5,485,000
-1,379,000
1,330,000
30,131,000
299,000
2,043,000
3,419,000
693,000
803,000
-155,704,000
-751,000
-1,799,000
-130,313,000
-2,696,000
21,355,000
20,063,000
32,000
22,660,000
-27,842,000
24,448,000
0
-29,274,000
0
0
0
-483,534,000
0
0
0
2,110,000
301,000
0
0
-5,721,000
0
0
0
-179,547,000
0
0
-1,902,000
18,135,000
0
0
0
14,691,000
0
0
0
-67,046,000
43,564,000
-44,131,000
0
-43,086,000
0
-3,007,000
-3,996,000
-9,903,000
26,576,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.